Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy
Status:
Recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
The purpose of this research is to gather information on the safety and efficacy of using a
prebiotic as an adjunctive therapy to peanut oral immunotherapy. The prebiotic is not an FDA
approved drug or medication rather a fiber found at local grocery stores.